Oscar Health, Inc. (NYSE: OSCR), a tech-driven healthcare company, is capturing headlines with its impressive 29% revenue growth. Operating within the competitive healthcare plans sector, Oscar Health has carved out..
Inspire Medical Systems, Inc. (NASDAQ: INSP) is making headlines with a notable potential upside of 53.85%, capturing the attention of investors seeking growth opportunities in the healthcare sector. Specializing in..
Avidity Biosciences, Inc. (NASDAQ: RNA), a trailblazer in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to RNA therapeutics. As a biopharmaceutical company,..
Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, continues to leverage its extensive footprint in the medical instruments and supplies industry. Headquartered in Vaughan, Canada, this..
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing the attention of investors with its impressive revenue growth and strategic partnerships. As a biopharmaceutical company,..
TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.92 billion, this Massachusetts-based company has been..
Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the niche market of diagnostic and therapeutic products. With a market..
Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 92.91%. Specializing in the discovery and development of..
Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves within the healthcare sector, particularly in biotechnology. Headquartered in Cambridge, Massachusetts, this innovative firm is dedicated to developing therapies..
BridgeBio Pharma, Inc. (NASDAQ: BBIO) is turning heads in the biotechnology sector with its ambitious approach to addressing genetic diseases and cancers. With a market capitalization of $9.89 billion, this..
Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, offers investors an intriguing opportunity with a noteworthy 38.93% potential upside based on current analyst ratings. As a..
Solventum Corporation (SOLV), a prominent player in the healthcare sector, stands out with its diverse portfolio of medical instruments and supplies. Headquartered in Maplewood, Minnesota, Solventum is making significant strides..
Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology industry, is drawing attention from investors with a potential upside of 19.55% based on current analyst target price projections. Headquartered..
Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical instruments and supplies industry. Headquartered in Waltham,..
Integer Holdings Corporation (NYSE: ITGR), with its roots firmly planted in the healthcare sector, operates as a significant player in the medical devices industry. Headquartered in Plano, Texas, and founded..
DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $9.85 billion, DaVita’s focus on..
Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, stands out in the stock market with an intriguing potential upside of 12.3%. With a market capitalization..
Avantor, Inc. (AVTR), a notable player in the healthcare sector, specializes in providing mission-critical products and services across various industries, including biopharma, healthcare, and advanced technologies. With a market capitalization..
Qiagen N.V. (QGEN), a Netherlands-based leader in the healthcare sector, is capturing investor attention with its robust diagnostics and research capabilities. With a market capitalization of $10.08 billion, Qiagen offers..
